12:00 AM
 | 
Sep 03, 2007
 |  BC Week In Review  |  Company News  |  Other News

Bolder BioTechnology, National Institutes of Health autoimmune news

Bolder received a $685,984 Phase II SBIR grant from NIH's National Institute of Arthritis and Musculoskeletal and...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >